Literature DB >> 8148442

Cytokine production and fatigue in patients with chronic fatigue syndrome and healthy control subjects in response to exercise.

A Lloyd1, S Gandevia, A Brockman, J Hales, D Wakefield.   

Abstract

We have studied the relationship between the cytokine production induced in vivo by prolonged isometric exercise and the symptom complex marked by fatigue in patients with chronic fatigue syndrome (CFS). Twelve male patients and 13 matched male control subjects undertook an isometric hand-grip exercise protocol utilizing dynamometers. Subjects undertook 30 minutes of exercise, for which the target force was set at 40% of the maximal voluntary contraction and the duty cycle was 50%. Prior to, during, and for 24 hours following the exercise, blood samples were collected and assayed for the presence of cytokines, including interferon-gamma and interferon-alpha, interleukin-1 beta, and tumor necrosis factor-alpha. At those times subjects also completed the Profile of Mood States (POMS) questionnaire, which served as a measure of changes in subjective fatigue. No significant alteration in the level of any of the cytokines in the plasma of patients or control subjects was detected before, during, or after exercise. Surprisingly, the patients' levels of fatigue, depression, and confusion, as measured by the POMS, decreased in response to the exercise. These data do not confirm the presence of an immunologic process correlating with the exacerbation of fatigue after exercise experienced by patients with CFS. Limitations in the study design and in the sensitivity of the cytokine assays may have affected our results.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8148442     DOI: 10.1093/clinids/18.supplement_1.s142

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  11 in total

1.  Immunological response in chronic fatigue syndrome following a graded exercise test to exhaustion.

Authors:  J J LaManca; S A Sisto; X D Zhou; J E Ottenweller; S Cook; A Peckerman; Q Zhang; T N Denny; W C Gause; B H Natelson
Journal:  J Clin Immunol       Date:  1999-03       Impact factor: 8.317

Review 2.  Evidence for the presence of immune dysfunction in chronic fatigue syndrome.

Authors:  Benjamin H Natelson; Mohammad H Haghighi; Nicholas M Ponzio
Journal:  Clin Diagn Lab Immunol       Date:  2002-07

Review 3.  Current concepts in the pathophysiology of fibromyalgia: the potential role of oxidative stress and nitric oxide.

Authors:  Salih Ozgocmen; Huseyin Ozyurt; Sadik Sogut; Omer Akyol
Journal:  Rheumatol Int       Date:  2005-11-20       Impact factor: 2.631

4.  Alteration of Interferon Gamma (IFN-γ) in Human Plasma with Graded Physical Activity.

Authors:  Ambarish Vijayaraghava; Radhika K
Journal:  J Clin Diagn Res       Date:  2014-06-20

Review 5.  Use of exercise for treatment of chronic fatigue syndrome.

Authors:  K K McCully; S A Sisto; B H Natelson
Journal:  Sports Med       Date:  1996-01       Impact factor: 11.136

6.  Elevation of bioactive transforming growth factor-beta in serum from patients with chronic fatigue syndrome.

Authors:  A L Bennett; C C Chao; S Hu; D Buchwald; L R Fagioli; P H Schur; P K Peterson; A L Komaroff
Journal:  J Clin Immunol       Date:  1997-03       Impact factor: 8.317

Review 7.  Chronic fatigue syndrome: an update.

Authors:  R J Shephard
Journal:  Sports Med       Date:  2001       Impact factor: 11.136

Review 8.  Effect of Acute Exercise on Fatigue in People with ME/CFS/SEID: A Meta-analysis.

Authors:  Bryan D Loy; Patrick J O'Connor; Rodney K Dishman
Journal:  Med Sci Sports Exerc       Date:  2016-10       Impact factor: 5.411

9.  Normal production of inflammatory cytokines in chronic fatigue and fibromyalgia syndromes determined by intracellular cytokine staining in short-term cultured blood mononuclear cells.

Authors:  M R Amel Kashipaz; D Swinden; I Todd; R J Powell
Journal:  Clin Exp Immunol       Date:  2003-05       Impact factor: 4.330

Review 10.  Interleukin-1 as a mediator of fatigue in disease: a narrative review.

Authors:  Megan E Roerink; Marieke E van der Schaaf; Charles A Dinarello; Hans Knoop; Jos W M van der Meer
Journal:  J Neuroinflammation       Date:  2017-01-21       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.